Japon bilim insanlar\u0131ndan olu\u015fan ara\u015ft\u0131rma ekibi, mesane k\u00fc\u00e7\u00fck h\u00fccreli karsinomunun (SmCC) molek\u00fcler yap\u0131s\u0131na ili\u015fkin yeni veriler sunarak kanser tedavisinde k\u00f6kl\u00fc de\u011fi\u015fikliklere kap\u0131 aralad\u0131. Mesane SmCC, nadir g\u00f6r\u00fclmesine ra\u011fmen son derece agresif seyriyle onkoloji prati\u011finde zorlu bir ba\u015fl\u0131k olarak kabul edilmektedir. Bu kanser tipi, \u00f6zellikle tan\u0131 ve tedavi s\u00fcre\u00e7lerinde kar\u015f\u0131la\u015f\u0131lan belirsizliklerle \u00f6n plana \u00e7\u0131karken, Japon ara\u015ft\u0131rmac\u0131lar\u0131n yapt\u0131\u011f\u0131 \u00e7al\u0131\u015fma, kanser h\u00fccrelerinin geli\u015fiminde rol oynayan belirli transkripsiyon fakt\u00f6rleri (TF) \u00fczerinden alt tip s\u0131n\u0131fland\u0131rmas\u0131 yaparak yeni ufuklar a\u00e7t\u0131.<\/p>\n
K\u00fc\u00e7\u00fck h\u00fccreli karsinomlar, \u00f6zellikle akci\u011fer ile \u00f6zde\u015fle\u015fmi\u015f n\u00f6roendokrin \u00f6zellikleri ve h\u0131zl\u0131 ilerleyi\u015fleriyle bilinir. Ancak akci\u011fer d\u0131\u015f\u0131 organlarda geli\u015fen k\u00fc\u00e7\u00fck h\u00fccreli karsinomlar, mesane gibi farkl\u0131 dokularda benzer patolojik \u00f6zellikler ta\u015f\u0131makla birlikte kendine \u00f6zg\u00fc molek\u00fcler ve histolojik farkl\u0131l\u0131klar da g\u00f6stermektedir. Bu nedenle, mesane SmCC\u2019nin kendi i\u00e7inde heterojen yap\u0131s\u0131n\u0131 anlamak, \u00f6zg\u00fcn geli\u015fim mekanizmalar\u0131n\u0131 \u00e7\u00f6zmek i\u00e7in transkripsiyon fakt\u00f6rlerinin ifadesinin de\u011ferlendirilmesi b\u00fcy\u00fck \u00f6nem ta\u015f\u0131maktad\u0131r.<\/p>\n
Ara\u015ft\u0131rma kapsam\u0131nda, Japonya\u2019n\u0131n \u00f6nde gelen bir kanser hastanesinden temin edilen dokuz mesane k\u00fc\u00e7\u00fck h\u00fccreli karsinom \u00f6rne\u011fi ile alt\u0131 prostat kaynakl\u0131 k\u00fc\u00e7\u00fck h\u00fccreli karsinom \u00f6rne\u011fi detayl\u0131 olarak incelendi. \u0130mm\u00fcnohistokimya y\u00f6ntemi kullan\u0131larak ASCL1, NEUROD1, POU2F3 ve YAP1 gibi h\u00fccresel kimlik ve farkl\u0131la\u015fmay\u0131 d\u00fczenleyen \u00f6nemli transkripsiyon fakt\u00f6rlerinin varl\u0131\u011f\u0131 de\u011ferlendirildi. Bu analizler, n\u00f6roendokrin belirte\u00e7lerle birlikte tumor alt tiplerinin molek\u00fcler haritalar\u0131n\u0131 \u00e7\u0131karmaya odakland\u0131.<\/p>\n
Ara\u015ft\u0131rman\u0131n \u00e7arp\u0131c\u0131 sonu\u00e7lar\u0131ndan biri, mesane SmCC \u00f6rneklerinde kombine k\u00fc\u00e7\u00fck h\u00fccreli karsinom ile \u00fcrotelyal karsinom (\u00dcK) ve adenokarsinom bile\u015fiminin y\u00fcksek oranda g\u00f6r\u00fclmesiydi. Mesane SmCC\u2019nin %78\u2019inde bu kombine (karma) histolojik bulgular tespit edilirken, prostat SmCC \u00f6rneklerinde yaln\u0131zca %17 oran\u0131nda benzer bir birliktelik saptand\u0131 (p=0.041). Bu durum, mesane k\u00fc\u00e7\u00fck h\u00fccreli karsinomlar\u0131n\u0131n, di\u011fer epitelyal kanserlerle birlikte ortaya \u00e7\u0131karak farkl\u0131 h\u00fccresel k\u00f6ken ya da farkl\u0131la\u015fma yollar\u0131n\u0131 yans\u0131tt\u0131\u011f\u0131n\u0131 g\u00f6stermesi a\u00e7\u0131s\u0131ndan \u00f6nemlidir.<\/p>\n
Bu biyolojik \u00e7e\u015fitlilik, NEUROD1 transkripsiyon fakt\u00f6r\u00fcn\u00fcn ifadesinde belirginle\u015fti. Sinirsel farkl\u0131la\u015fma ile ili\u015fkilendirilen NEUROD1, mesane SmCC \u00f6rneklerinin %67\u2019sinde pozitif bulunurken, prostat SmCC\u2019de hi\u00e7 tespit edilmedi (p=0.028). Bu farkl\u0131l\u0131k, NEUROD1\u2019nin mesane k\u00f6kenli k\u00fc\u00e7\u00fck h\u00fccreli karsinomun karakteristik bir belirteci oldu\u011funu savunuyor ve t\u00fcm\u00f6r davran\u0131\u015f\u0131yla ilgili yeni tedavi hedeflerinin belirlenmesinde anahtar rol oynayabilir.<\/p>\n
Dahas\u0131, mesanedeki k\u00fc\u00e7\u00fck h\u00fccreli karsinom \u00f6rnekleri kendi i\u00e7inde de NEUROD1 ifadesine g\u00f6re ayr\u0131\u015ft\u0131. Kombine SmCC-\u00dcK \u00f6rneklerinin tamam\u0131 (%100) NEUROD1 pozitif bulunurken, di\u011fer mesane SmCC\u2019lerde bu oran yaln\u0131zca %25 idi (p=0.048). \u00dcrotelyal farkl\u0131la\u015fman\u0131n NEUROD1 aktivitesini tetikledi\u011fini ya da bu yolaklarla ili\u015fkilendirildi\u011fini d\u00fc\u015f\u00fcnd\u00fcren bu bulgu, t\u00fcm\u00f6r geli\u015fiminde farkl\u0131 h\u00fccresel alt tiplerin rol\u00fcn\u00fc i\u015faret ediyor.<\/p>\n
Ara\u015ft\u0131rmadaki bir di\u011fer \u00f6nemli veri, kar\u0131\u015f\u0131k mesane SmCC ve \u00fcrotelyal karsinom bile\u015fenlerinde HNF4A transkripsiyon fakt\u00f6r\u00fcn\u00fcn tamamen kaybolmu\u015f olmas\u0131d\u0131r. HNF4A, daha \u00f6nce karaci\u011fer ve gastrointestinal dokularda farkl\u0131la\u015fma ile ili\u015fkilendirilmi\u015f bir fakt\u00f6rd\u00fcr. Mesane SmCC\u2019nin di\u011fer alt tiplerinde ise %75 oran\u0131nda HNF4A pozitifli\u011fi tespit edildi (p=0.048). Bu durum, mesane SmCC i\u00e7erisinde farkl\u0131la\u015fma yolaklar\u0131n\u0131n varl\u0131\u011f\u0131n\u0131 ve ayn\u0131 zamanda hedefe y\u00f6nelik tedavi yakla\u015f\u0131mlar\u0131 i\u00e7in yeni f\u0131rsatlar sunmaktad\u0131r.<\/p>\n
\u0130ncelenen iki mesane SmCC \u00f6rne\u011finde NEUROD1 ve POU2F3 fakt\u00f6rlerinin kar\u015f\u0131l\u0131kl\u0131 olarak birbirini d\u0131\u015flayan (mutually exclusive) \u015feklinde ifade edilmesi de dikkat \u00e7ekiciydi. N\u00f6roendokrin belirte\u00e7lerin sadece NEUROD1 pozitif h\u00fccrelerde lokalize olmas\u0131, t\u00fcm\u00f6r i\u00e7inde farkl\u0131 h\u00fccresel pop\u00fclasyonlar\u0131n birlikte bulunabilece\u011finin kan\u0131t\u0131yd\u0131. Bu intratumoral heterojenlik, t\u00fcm\u00f6r biyolojisi ve ilerlemesine ili\u015fkin karma\u015f\u0131k genetik ve epigenetik d\u00fczenlemelerin g\u00f6stergesi olarak yorumlanmaktad\u0131r.<\/p>\n
Ara\u015ft\u0131rman\u0131n sundu\u011fu TF tabanl\u0131 alt tip s\u0131n\u0131fland\u0131rmas\u0131, mesane SmCC\u2019nin geleneksel histopatolojik s\u0131n\u0131fland\u0131rman\u0131n \u00f6tesinde molek\u00fcler d\u00fczeyde ayr\u0131\u015ft\u0131r\u0131lmas\u0131na olanak tan\u0131makta, hasta baz\u0131nda daha spesifik ve etkili tedavilere zemin haz\u0131rlamaktad\u0131r. Bu yakla\u015f\u0131m, prognozun daha do\u011fru tahmin edilmesi ve tedavi yan\u0131t\u0131n\u0131n optimize edilmesinde klinisyenler i\u00e7in de\u011ferli bir ara\u00e7 haline gelebilir.<\/p>\n
Bununla birlikte, mesane ve prostat k\u00fc\u00e7\u00fck h\u00fccreli karsinomlar\u0131 aras\u0131ndaki belirgin molek\u00fcler farkl\u0131l\u0131klar, her iki kanser tipi i\u00e7in ayr\u0131 tan\u0131 kriterleri ve tedavi protokollerinin geli\u015ftirilmesi gerekti\u011finin \u00f6nemini ortaya koymaktad\u0131r. Akci\u011fer veya prostat SmCC tedavi yakla\u015f\u0131mlar\u0131n\u0131n mesane kanserine direkt uygulanmas\u0131n\u0131n s\u0131n\u0131rl\u0131l\u0131klar\u0131n\u0131 vurgulayan bu bulgular, tedavi stratejilerinin doku ve molek\u00fcler profile \u00f6zg\u00fc \u015fekilde \u015fekillendirilmesi gerekti\u011fine i\u015faret etmektedir.<\/p>\n
Transkripsiyon fakt\u00f6r\u00fc profillemesi, genomik ve proteomik verilerle entegre edilerek t\u00fcm\u00f6rlerin kapsaml\u0131 molek\u00fcler haritalar\u0131n\u0131n \u00e7\u0131kar\u0131lmas\u0131, gelece\u011fin onkologlar\u0131na yeni biyobelirte\u00e7ler ve hedefler sunabilir. Bu \u00e7ok boyutlu analizler, tedaviye yan\u0131t, n\u00fcks riski ve genel sa\u011fkal\u0131m \u00fczerine daha net \u00f6ng\u00f6r\u00fcler yap\u0131lmas\u0131n\u0131 sa\u011flayabilir.<\/p>\n
Kitahama ve meslekta\u015flar\u0131n\u0131n \u00f6nc\u00fcl\u00fc\u011f\u00fcn\u00fc yapt\u0131\u011f\u0131 bu \u00e7al\u0131\u015fma, mesane k\u00fc\u00e7\u00fck h\u00fccreli karsinomunu transkripsiyon fakt\u00f6r biyolojisi temelinde yeniden tan\u0131mlama ad\u0131na \u00f6nemli bir ad\u0131m niteli\u011findedir. Kanser tedavisinde \u201cher hasta farkl\u0131d\u0131r\u201d yakla\u015f\u0131m\u0131n\u0131 peki\u015ftirerek, alt t\u00fcrlere dayal\u0131 klinik algoritmalar\u0131n geli\u015ftirilmesini te\u015fvik etmektedir.<\/p>\n
K\u00fc\u00e7\u00fck h\u00fccreli karsinomlarla ilgili ara\u015ft\u0131rmalar ilerledik\u00e7e, t\u00fcm\u00f6rdeki h\u00fccresel k\u00f6kenin ve fenotipin molek\u00fcler belirte\u00e7lerle saptanmas\u0131n\u0131n \u00f6nemi daha da netle\u015fmektedir. Bu \u00e7al\u0131\u015fma, molek\u00fcler alt tiplerin sadece teorik bir s\u0131n\u0131fland\u0131rma de\u011fil, ger\u00e7ek klinik fayda sa\u011flayan ara\u00e7lar oldu\u011funa dair g\u00fc\u00e7l\u00fc bir kan\u0131t sunuyor.<\/p>\n
B\u00fcy\u00fck hasta gruplar\u0131nda do\u011frulamalar yap\u0131ld\u0131\u011f\u0131nda ve bu molek\u00fcler parametreler rutin tan\u0131 s\u00fcre\u00e7lerine dahil edildi\u011finde, transkripsiyon fakt\u00f6r temelli alt tip s\u0131n\u0131fland\u0131rmas\u0131 mesane k\u00fc\u00e7\u00fck h\u00fccreli karsinomunun y\u00f6netiminde temel bir unsur haline gelebilir. Bu alt tiplerin mevcut kemoterapilere, hedefe y\u00f6nelik ajanlara ya da imm\u00fcnoterapilere yan\u0131tlar\u0131n\u0131n ara\u015ft\u0131r\u0131lmas\u0131, yeni tedavi kap\u0131lar\u0131n\u0131n aralanmas\u0131n\u0131 sa\u011flayacakt\u0131r.<\/p>\n
Sonu\u00e7 olarak, \u00f6zellikle \u00fcrotelyal karsinom bile\u015fimiyle birlikte g\u00f6r\u00fclen mesane SmCC\u2019de NEUROD1\u2019nin belirgin rol\u00fc, hastal\u0131k heterojenitesini \u00e7\u00f6zmenin ve tedavi yakla\u015f\u0131mlar\u0131n\u0131 ki\u015fiselle\u015ftirmenin kritik bir unsuru olarak ortaya \u00e7\u0131kmaktad\u0131r. Bu ke\u015fif, hem bilim d\u00fcnyas\u0131na hem de klinisyenlere hastaya \u00f6zg\u00fc tan\u0131 ve tedavi s\u00fcre\u00e7lerinin geli\u015ftirilmesi yolunda yeni perspektifler sunmaktad\u0131r.<\/p>\n
Ara\u015ft\u0131rma Konusu<\/strong>: Makale Ba\u015fl\u0131\u011f\u0131<\/strong>: Haberin Yay\u0131n Tarihi<\/strong>: Web References<\/strong>: Doi Referans<\/strong>: Resim Credits<\/strong>: Anahtar Kelimeler<\/strong>: Japon bilim insanlar\u0131ndan olu\u015fan ara\u015ft\u0131rma ekibi, mesane k\u00fc\u00e7\u00fck h\u00fccreli karsinomunun (SmCC) molek\u00fcler yap\u0131s\u0131na ili\u015fkin yeni veriler sunarak kanser tedavisinde k\u00f6kl\u00fc de\u011fi\u015fikliklere kap\u0131 aralad\u0131. Mesane SmCC, nadir g\u00f6r\u00fclmesine ra\u011fmen son derece agresif seyriyle onkoloji prati\u011finde zorlu bir ba\u015fl\u0131k olarak kabul edilmektedir. Bu kanser tipi, \u00f6zellikle tan\u0131 ve tedavi s\u00fcre\u00e7lerinde kar\u015f\u0131la\u015f\u0131lan belirsizliklerle \u00f6n plana \u00e7\u0131karken, Japon ara\u015ft\u0131rmac\u0131lar\u0131n…<\/p>\n","protected":false},"author":1,"featured_media":3719,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_yoast_wpseo_title":"","_yoast_wpseo_metadesc":"","_yoast_wpseo_focuskw":"","rank_math_title":"","rank_math_description":"","rank_math_focus_keyword":"","_wpan_schema_json_ld":"","_wpan_ai_seo_metadata":"","_wpan_ai_seo_status":"","_wpan_ai_seo_policy":"","_wpan_ai_seo_faq_block":"","_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[28],"tags":[2829,2831,2832,2833,2830],"tmauthors":[],"class_list":{"0":"post-3718","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-kanser","8":"tag-mesane-kucuk-hucreli-karsinom-molekuler-alt-tipleri","9":"tag-mesane-smcc-ve-noroendokrin-belirtecler","10":"tag-mesane-ve-prostat-kucuk-hucreli-karsinom-karsilastirmasi","11":"tag-neurod1-transkripsiyon-faktoru-mesane-kanseri","12":"tag-transkripsiyon-faktorleri-mesane-kanseri-alt-tip-siniflandirmasi"},"jetpack_featured_media_url":"https:\/\/haber360.com\/wp-content\/uploads\/2025\/04\/Mesane-Kanserinde-Transkripsiyon-Faktor-Alt-Tipleri-1745487899.jpg","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/posts\/3718","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/comments?post=3718"}],"version-history":[{"count":0,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/posts\/3718\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/media\/3719"}],"wp:attachment":[{"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/media?parent=3718"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/categories?post=3718"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/tags?post=3718"},{"taxonomy":"tmauthors","embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/tmauthors?post=3718"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\nClinicopathological and transcription factor-defined subtypes in bladder small cell carcinoma and their comparison with prostate small cell carcinoma.<\/p>\n
\nClinicopathological characteristics of transcription factor-defined subtypes in bladder small cell carcinoma<\/p>\n
\n2025<\/p>\n
\nhttps:\/\/doi.org\/10.1186\/s12885-025-14157-1<\/p>\n
\nhttps:\/\/doi.org\/10.1186\/s12885-025-14157-1<\/p>\n
\nScienmag.com<\/p>\n
\naggressive bladder malignancies, bladder cancer, transcription factors, cancer diagnosis challenges, contrasting prostate and bladder cancer, heterogeneity in small cell carcinoma, immunohistochemistry in cancer studies, Japan cancer research study, lineage-specific transcription factors, neuroendocrine tumors in bladder, small cell carcinoma research, therapeutic options for bladder cancer, transcription factor subtypes in oncology<\/p>\n","protected":false},"excerpt":{"rendered":"